132 results
Page 3 of 7
8-K
EX-99.1
r05dlhx b5
2 Mar 21
Other Events
4:30pm
8-K
EX-10.1
1hv7jd0rvjfshsv
30 Dec 20
Entry into a Material Definitive Agreement
4:44pm
8-K
EX-99.1
n5ocjq7 3p9ib2h5
10 Nov 20
Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
4:31pm
8-K
EX-99.1
92qkp959z0d6ww7pc
13 Aug 20
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
4:36pm
8-K/A
da5wbnvs6frsi
1 Jun 20
Other Events
12:00am
8-K/A
EX-99.2
k4rpf kwn1sm1hedw5yx
1 Jun 20
Other Events
12:00am
8-K/A
EX-99.3
rvw9hgxow8tiud2qxi3
1 Jun 20
Other Events
12:00am
8-K
EX-99.1
2ms3j3sj
28 May 20
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
4:41pm
DEFA14A
1wz0k fs9e
28 Feb 20
Additional proxy soliciting materials
9:10am
8-K
EX-99.1
20entvl rhn66m5r
28 Feb 20
NewLink Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
9:08am
DEFR14A
xb5fu ig424xdbr38yu
13 Feb 20
Revised proxy
4:37pm
DEFM14A
lvlrcmom4qgbsr
10 Feb 20
Proxy related to merger
8:30am